Intrinsiqq
RetinalGenix Technologies Inc. logo

RetinalGenix Technologies Inc. Financials

RTGN

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 6 available years
Income Statement
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Cost of Revenue–––-$2-$2
General & Administrative$1$1$1$1$1
Research & Development$0$0$1$1$1
Total Operating Expenses$2$4$2$4$2
Non-Operating
Net Interest Expense-$0-$0-$0-$0-$0
Net Income
Net Income-$2-$4-$2-$4-$2
EPS (Basic)-$0.13-$0.24-$0.12-$0.25-$0.05
EPS (Diluted)-$0.13-$0.24-$0.12-$0.25-$0.05
Weighted Avg Shares (Basic)18.6M17.9M17.4M15.6M41.2M
Weighted Avg Shares (Diluted)18.6M17.9M17.4M15.6M41.2M
Shares Outstanding18.6M17.9M17.4M15.6M41.2M

RetinalGenix Technologies (RTGN) financials: revenue, profit and margins

RetinalGenix Technologies (RTGN) generated about n/a in revenue and -$2 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is RetinalGenix Technologies profitable?+

RetinalGenix Technologies reported about -$2 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 16 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 17 Nov 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with RTGN

CompareIntrinsic value
TNONTenon Medical Inc.
$0.90-9.01%40
BTCYBiotricity Inc.
$0.06+33.33%40
PAVMPAVmed Inc.
$1.14-5.42%35
PETVPetvivo Holdings Inc
$0.31+3.33%23
NSPRInspireMD Inc.
$0.54-12.90%25
VTAKCatheter Precision, Inc.
$0.39-7.14%50
PMIPicard Medical, Inc.
$6.79+7.78%30
VVOSVivos Therapeutics, Inc.
$0.05-5.26%26

Spot a number that looks wrong? Check it in RTGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing RTGN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.